A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

NCT03156127 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Problem of Investigational Products

Conditions

Uterine Myoma

Interventions

DRUG: BR-UPS 5 mg tablet, Inisia 5 mg tablet

Sponsor

Boryung Pharmaceutical Co., Ltd